An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the service has removed violative content and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also discovered communities with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, glowing reviews and step-by-step guides for preparing or administering at home.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Product Details and Costs
Inside these groups, messages display black plastic packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly significant medical dangers”.
